Summary The reactivity of alpha-l-antitrypsin (AAT) with Lens culinaris agglutinin (LCA) was studied by crossed immuno-affinity electrophoresis of the sera of 246 subjects from 6 groups (acute virus hepatitis, chronic hepatitis, liver cirrhosis, hepatocellular carcinoma (HCC), carcinoma metastatic to the liver and normal controls). Two species of AAT (LCA-reactive and -nonreactive species) were detected on crossed immuno-affinity electrophoresis in a gel containing LCA. The percentages of LCA-reactive species of AAT in neoplastic diseases of the liver were significantly higher than those in benign liver diseases and normal controls. There was no correlation between the percentage of LCA-reactive species of AAT and serum AAT concentration in any group. Furthermore, in studying 15 pairs of serum samples before and after the subsequent development of HCC, the percentage of LCA-reactive species of AAT after HCC occurrence was significantly higher than that before, although there was no statistically significant difference between the serum AAT concentration before and after development of the disease. The latter 15 patients were all of the normal protease inhibitor phenotype (PiMM) and no change in phenotype was observed before and after the development of HCC. The results indicate that measurement of the reactivity of AAT with LCA can be a useful marker for the diagnosis of HCC and carcinoma metastatic to the liver, especially when serum concentrations of alpha-foetoprotein or other tumour markers are within the normal ranges.
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Alpha-1-antitrypsin (AAT), one of the most important serum protease inhibitors, neutralizes the activity of enzymes such as elastase, trypsin and chymotrypsin, and is known as an acute phase reactant. Genetical polymorphism of AAT was reported by many investigators and about 30 genetic variants have been recognized (Carrel et al., 1982) . Hereditary deficiency is predisposed to degenerative lung disease, and in some instances, to liver disease (Laurell & Eriksson, 1963; Sharp et al., 1969 ).
An increased incidence of hepatocellular carcinoma (HCC) in adults with Pi (protease inhibitor) ZZ has been reported (Berg & Eriksson, 1972; Eriksson & Hagerstrand, 1974) . This genetic deficiency is virtually confined to Europeans, some 10% of whom are carriers of a pathological variant (Carell et al., 1982) . However, approximately 99% of the general population have the normal protease inhibitor phenotype (PiMM) in Japan (Miyake et al., 1980) . Early detection of HCC is very important during the follow-up of patients with chronic liver diseases. The measurement of serum alpha-foetoprotein (AFP) concentration has been used extensively for the detection of HCC. Furthermore, our previous studies have shown that measurement of the fucosylated fraction of AFP is very useful for the early diagnosis of HCC and that it can distinguish an AFP species due to malignancy from one due to benign liver diseases (Aoyagi et al., 1984 (Aoyagi et al., , 1985a (Aoyagi et al., ,b, 1986 . There are, however, also HCCs, the corresponding serum AFP concentrations of which are within the normal range.
In this paper, we tested the reactivity of AAT with Lens culinaris agglutinin (LCA) to evaluate its usefulness in the diagnosis of liver diseases, and we found that measurement of LCA-reactive species of AAT could be utilized for the diagnosis of neoplastic diseases of the liver. Patients and methods
Patients
Sera of 246 subjects from 6 groups were used. As summarized in Table I 
Results
Crossed immuno-affinity electrophoresis patterns of AA T Two species of AAT were detected on crossed immunoaffinity electrophoresis in a gel containing LCA. Migration of one of the two AAT species was retarded (LCA-reactive species) and that of the other remained unchanged (LCAnonreactive species). When crossed immuno-affinity electrophoresis in each gel containing 0.1, 0.3, 0.5 and 1.0 mg ml -1 of soluble LCA was performed, the best immunoprecipitation pattern was obtained in the gel containing 0.5 mg ml 'of soluble LCA, as shown in Figure 1 . Therefore, we adopted the gel containing 0.5mgml-P of soluble LCA in the first dimension. Typical crossed immuno-affinity electrophoresis patterns of AAT of a patient with liver cirrhosis and a patient with HCC are shown in Figure 2 . The percentage of LCA-reactive species of AAT in HCC was markedly higher than that in cirrhosis.
LCA-reactive species of AA T and serum AA T concentration As shown in Figure 3 and Table I , the percentages of LCAreative species of AAT in neoplastic diseases of the liver were significantly higher than those in benign liver diseases and normal controls (group 4 vs. group 1, P<0.01; group 4 vs. group 2, 3 and 6, P<0.001; group 5 vs. group 1, P<0.1; group 5 vs. group 3, P <0.02; group 5 vs. group 2 and 6, P<0.001). Furthermore, in HCC, there were 9 patients whose serum AFP concentrations were <10ngml-1. Three (33%) of them showed over 30% of LCA-reactive species of AAT. Serum AAT concentrations in neoplastic diseases of the liver were also significantly higher than those in benign liver diseases and normal controls (group 5 vs. group 1, 2, 3, 4 and 6, P<0.001: group 4 vs. group 2, P<0.05; group 4 vs. group 3 and 6, P<0.001). Details are given in Table I and Figure 4 . However, there was no correlation between the percentage of LCA-reactive species of AAT and serum AAT concentration in any group (group 1, r = 0.204, y=0.018x+ 10.17; group 2, r= -0.171, y= -0.013x+ 13.38; group 3, r = -0.042, y = -0.005x + 14.57; group 4, r = 0.040, y=0.004x+ 18.17; group 5, r=0.296, y=0.024x+9.878; group 6, r=0.127, y=0.016x+5.191). In HCC especially, 10 (34%) of 29 patients whose serum AAT concentrations were within the normal range showed more than 20% of LCAreactive species of AAT.
When we compared LCA-reactive species of AAT in the acute stage of acute virus hepatitis with that in the convalescent stage, there was no significant difference between them (acute stage, 16+4%; convalescent stage, 14+6%). However, serum AAT concentration in the acute stage (302 +43mg dl-1) was significantly higher than that in convalescence (232 + 54mg dl-1, P <0.001). Additionally, there was no significant difference between chronic active hepatitis and chronic inactive-hepatitis patients in either LCA-reactive species of AAT or serum AAT concentration.
Next, we tested 15 pairs of serum samples from patients with a long history of chronic liver diseases before and after the subsequent development of HCC. The percentage of LCA- reactive species of AAT after HCC development (21+9%) was significantly higher than before (11+5%, P<0.001), although there was no significant difference in serum AAT concentrations before (225 + 30mg dl -1) and afterwards (252 + 52 mg dl 1) ( Figure 5 ).
Phenotyping of AAT Polyacrylamide gel slab isoelectric focusing was performed to determine AAT phenotypes in the above 15 pairs of serum samples. All of the phenotypes were PiMM and no change in phenotype was observed before and after the development of HCC. PiMM subtypes were M 1 M l (11 patients), M1 M2 (2) and M2M3 (2).
Relationship between LCA -reactive species of AA T and the anatomic extent of HCC We investigated the relationship between the percentage of LCA-reactive species of AAT and the anatomic extent of HCC (stage El, E2, E3 and E4). Figure 6 . 
Discussion
Our previous studies have shown that measurement of LCAreactive species of AFP is much more useful than that of serum AFP concentration for the early diagnosis of HCC and that it can distinguish an AFP species due to HCC from one due to benign liver diseases. The molecular basis for this LCA-reactive species of AFP is fucosylation of the sugar chain (Aoyagi et al., 1984 (Aoyagi et al., , 1985a (Aoyagi et al., , b, 1986 (Palmer & Wolfe, 1976; Palmer et al., 1980; Ord6fiez & Manning, 1984) that immunoreactive AAT is present in HCC cells by the immunoperoxidase method, it was suggested that HCC cells might produce AAT, of an abnormal type i.e., that the change in the reactivity of AAT with LCA occurs in association with neoplastic transformation of hepatocytes, irrespective of serum AAT concentration. During the followup of the patients with chronic liver diseases, measurement of LCA-reactive species of AAT might thus be useful for the diagnosis of HCC, especially when serum AFP concentration is within the normal range. In fact, elevation of LCAreactive species of AAT led us to find HCC in some patients with liver cirrhosis.
The LCA-reactive species of AFP is known to contain a carbohydrate chain of the fucosylated biantennary complex type and most of the patients with HCC are known to have an elevated serum concentration of fucosylated AFP (Aoyagi et al., 1984 (Aoyagi et al., , 1985a (Aoyagi et al., ,b, 1986 . Since a carbohydrate structure of AAT is similar to that of AFP (Mega et al., 1980) , LCAreactive species of AAT is supposed to be a fucosylated fraction.
A characteristic feature of AAT is the multiple banding that is shown by isoelectric focusing. This banding is the result of microheterogeneity due to variations in its carbohydrate structure and a single amino acid substitution (Carell et al., 1982) . Therefore in order to investigate whether AAT phenotypes might change before and after the subsequent development of HCC, polyacrylamide gel slab isoelectric focusing was performed, using 15 pairs of serum samples. The result showed that all of the phenotypes were PiMM and that no change in phenotype was observed. In reference to the subtypes, PiM2M3, thought to be a predisposing factor to developing to chronic liver disease, was detected in 2 cases (13%) and this frequency was consistent with that of an earlier report (Miyake et al., 1980) .
